← Back to Search

Cardiovascular Risk Assessment for Rheumatoid Arthritis (CARE RA Trial)

N/A

Recruiting

Led By Iris Navarro-Milan, MD

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 40 and 75 years (inclusive)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post-intervention

Awards & highlights

CARE RA Trial Summary

This trial will develop an intervention to improve lipid screening and management in RA patients in order to decrease the risk for heart attacks and strokes.

Who is the study for?

This trial is for US residents aged 40-75 with Rheumatoid Arthritis who haven't had a cholesterol test in the past 2 years or discussed results with a doctor. Participants must speak English, have a phone and internet access, and be willing to work with a peer coach.Check my eligibility

What is being tested?

The study tests an intervention aimed at improving cholesterol screening and management in RA patients. It involves patient education and decision support programs to help reduce heart attack and stroke risk by managing high cholesterol.See study design

What are the potential side effects?

Since this trial focuses on cardiovascular risk assessment rather than medication, it does not directly involve drug-related side effects. However, any new interventions may cause stress or anxiety related to health awareness.

CARE RA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 40 and 75 years old.

CARE RA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of subjects screened for hyperlipidemia

Number of subjects who initiated a statin

Secondary outcome measures

General Self-Efficacy Scale (GSF) score

Medication Understanding and Use Self-Efficacy Scale (MUSE) score

Patient Activation Measure (PAM) score - 13 item

+3 more

CARE RA Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Peer coach guided online learning programExperimental Treatment1 Intervention

Group II: Self-administered online learning programPlacebo Group1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor

1,054 Previous Clinical Trials

1,316,181 Total Patients Enrolled

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH

484 Previous Clinical Trials

1,086,879 Total Patients Enrolled

44 Trials studying Rheumatoid Arthritis

560,879 Patients Enrolled for Rheumatoid Arthritis

Iris Navarro-Milan, MDPrincipal InvestigatorWeill Medical College of Cornell University

Media Library

Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis Clinical Trial Eligibility Overview. Trial Name: NCT04488497 — N/A

Rheumatoid Arthritis Research Study Groups: Peer coach guided online learning program, Self-administered online learning program

Rheumatoid Arthritis Clinical Trial 2023: Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis Highlights & Side Effects. Trial Name: NCT04488497 — N/A

Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis 2023 Treatment Timeline for Medical Study. Trial Name: NCT04488497 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been recruited for this research endeavor?

"Affirmative. The clinicaltrials.gov website displays that this research project is presently accepting applications, which were first published on January 27th 2021 and last changed on January 26th 2022. 128 participants are needed from a single medical centre to complete the study."

Answered by AI

What is the fundamental purpose of this medical experiment?

"During the 3-month post-intervention period, this clinical trial seeks to evaluate how many participants initiate a statin. Secondary outcomes will be measured using three different scales – Medication Understanding and Use Self Efficacy Scale (MUSE), Social Support Survey Score, and Patient Activation Measure (PAM). The MUSE score ranges from 8-32; higher scores signify increased self efficacy in understanding medication use. For the Social Support Survey Score, values range from 1-5 with an average of 70 indicating high support levels. Lastly, PAM Scores begin at 0-52 with a standardized activation score ranging from 0-100 which"

Answered by AI

Is the age criterion for this trial set at 75 years or younger?

"For this medical trial, individuals aged 40 to 75 years old are being recruited."

Answered by AI

Is this experiment presently accessible to participants?

"Correct. The information available on clinicaltrials.gov verifies that this medical experiment, initially listed in January of 2021, is still actively recruiting participants. Specifically, 128 individuals need to be recruited from a single site for the trial's completion."

Answered by AI